TriLink wins second China patent for CleanCap mRNA technology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LRCX
6. LVS
7. CSX
8. SAP
9. QGEN
10. ELV

Go back to TriLink wins second China patent for CleanCap mRNA technology

TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP

September 29, 2026 4:01 PM EDT

New Patent Protects the CleanCap® Cap Analog Compounds Themselves and mRNA-Based Pharmaceutical Compositions Extending Beyond Method Claims to Cover the Molecules at the Heart of Modern mRNA Medicines

SAN DIEGO--(BUSINESS WIRE)-- TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, today announced it has been granted a new patent from the China National Intellectual Property Administration (CNIPA), Patent number ZL202511246658.5., named "Compositions and Methods for Synthesizing 5'-Capped RNAs." The patent marks TriLink's second granted CleanCap®... More